Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Validation of an Artificial Intelligence System for Biliary Tract Cancer Screening Using Non-Contrast Computed Tomography

NCT07911397 is registered in ClinicalTrials.gov with Beijing Tsinghua Chang Gung Hospital as lead sponsor.

NCT NCT07911397 Not yet recruiting Not applicable 10,000 participants (estimated) Started 2026 1 site

Follow this trial by email Email me the PDF

Get the NCT07911397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started October 2026. Interventional study, 10,000 participants (estimated). Lead sponsor Beijing Tsinghua Chang Gung Hospital; China. Primary measure: Patient-level area under the receiver operating characteristic curve (AUC) of the AI system...

How it compares

53 similar trials: same condition (Biliary Tract Neoplasms) and phase

Enrollment

This trial
10,000
Middle half
52 to 158
Median
100
Trials with a value
53

Months from start to completion

This trial
4.9
Middle half
24 to 42
Median
35.9
Trials with a value
53

Sites

This trial
1
Middle half
1 to 1
Median
1
Trials with a value
49
Posted results or a linked paper 45% 24 of 53 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Validation of an Artificial Intelligence System for Biliary Tract Cancer Screening Using Non-Contrast Computed Tomography
Lead sponsor
Beijing Tsinghua Chang Gung Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
February 28, 2027
Enrollment
10,000 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Biliary Tract Neoplasms

Registry terms: biliary tract cancer (btc)

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
Yes
Study type
Interventional
Sites
1
Countries
China
Lead sponsor
Beijing Tsinghua Chang Gung Hospital

Arms

As registered; 1 arm.

Registered arms
Arm Type Interventions
AI-Assisted NCCT Screening Experimental AI-Assisted Biliary Tract Cancer Screening Using NCCT
Show registry wording

Participants in this arm will undergo AI-assisted screening for biliary tract cancer using non-contrast computed tomography (NCCT). The artificial intelligence system will independently analyze eligible NCCT examinations and generate a patient-level risk score for biliary tract cancer. The AI output will be evaluated against a predefined clinical reference standard. Routine clinical interpretation and patient management will not be replaced by the AI system.

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Patient-level area under the receiver operating characteristic curve (AUC) of the AI system for distinguishing biliary tract cancer from non-biliary-tract-cancer cases using non-contrast computed tomography (NCCT) From the index NCCT examination to completion of the reference standard assessment, up to 30 days
Show registry wording

The primary outcome is the patient-level area under the receiver operating characteristic curve (AUC) for the AI system in distinguishing biliary tract cancer from non-biliary-tract-cancer cases using non-contrast computed tomography (NCCT). Biliary tract cancer includes intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and gallbladder cancer. The reference diagnosis will be established using the predefined clinical reference standard.

Lead sponsor's other trials

Beijing Tsinghua Chang Gung Hospital, most recent start first.

Similar trials

Same condition (Biliary Tract Neoplasms) and phase, most recent start first.